Atavistik Bio
Industry
- Digital Health
- Artificial Intelligence
- Biotechnology
- Drug Discovery Technologies
- Pharmaceuticals
See more in Biomedtracker
Latest on Atavistik Bio
Scrip
• By Joseph Haas and Dexter Jie Yan
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Regeneron Bolsters Ophthalmic Portfoli
Scrip
• By Mandy Jackson
The end of 2023 is proving no different from the end of any other year, with venture capital firms and biopharmaceutical companies closing out a flurry of new VC funds and financings before December d
Scrip
• By Mandy Jackson
The amount of venture capital raised during the second quarter of 2021 was almost double the total raised in the second quarter of 2020, but the biggest reason that biopharma financings jumped from $3